Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Nsubuga

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 25, 2000
Efficacy of an unsupervised 8-month rifampicin-containing regimen for the treatment of pulmonary tuberculosis in HIV-infected adults. Uganda-Case Western Reserve University Research CollaborationJ L Johnson, A Okwera, P Nsubuga, et al.
Global Public Health|November 17, 2009
Implementing Integrated Disease Surveillance and Response: Four African countries' experience, 1998-2005P Nsubuga, W G Brown, S L Groseclose, et al.
American Journal of Respiratory and Critical Care Medicine|December 16, 1998
Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research CollaborationJ L Johnson, S Nyole, A Okwera, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 30, 2012
Reasons for non-participation in an international multicenter trial of a new drug for tuberculosis treatmentD Lamunu, K N Chapman, P Nsubuga, et al.
Clinical Pharmacology and Therapeutics|January 27, 2017
Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trialsR M Savic, M Weiner, W R MacKenzie, et al.
AIDS (London, England)|October 31, 2001
Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adultsJ L Johnson, A Okwera, D L Hom, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 25, 2000
Efficacy of an unsupervised 8-month rifampicin-containing regimen for the treatment of pulmonary tuberculosis in HIV-infected adults. Uganda-Case Western Reserve University Research CollaborationJ L Johnson, A Okwera, P Nsubuga, et al.
Global Public Health|November 17, 2009
Implementing Integrated Disease Surveillance and Response: Four African countries' experience, 1998-2005P Nsubuga, W G Brown, S L Groseclose, et al.
American Journal of Respiratory and Critical Care Medicine|December 16, 1998
Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research CollaborationJ L Johnson, S Nyole, A Okwera, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 30, 2012
Reasons for non-participation in an international multicenter trial of a new drug for tuberculosis treatmentD Lamunu, K N Chapman, P Nsubuga, et al.
Clinical Pharmacology and Therapeutics|January 27, 2017
Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trialsR M Savic, M Weiner, W R MacKenzie, et al.
AIDS (London, England)|October 31, 2001
Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adultsJ L Johnson, A Okwera, D L Hom, et al.
Pageof 2